Affect of Dose Rate on UVR Induced Skin Erythema
NCT00785187 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2008-11-05
Summary
Purpose of study: Evaluation of the affect of dose rate on UVR induced skin erythema.
Study design: A single-center, prospective, randomized, crossover, open study.
Number of patients: 20-40
Patient population: Healthy volunteers
Control: Different sites on patients body
Procedure duration: Total 3-5 hours (4 visits)
Duration of follow up: 4 days
Duration of study: Up to 6 months
Primary objectives: To examine the difference in erythemal response as a function of dose rate, and to assess the total amount of energy that is theoretically transmitted through a sunscreen within the range of SPF 2-10.
Conditions
- Erythema
Interventions
- DEVICE
-
exposure to UVB radiation
exposure to UVB radiation for limited time in order to establish subject's minimal erythema dose.
Sponsors & Collaborators
-
Goldenhersh, Michael, M.D.
lead INDIV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2009-02-28
More Related Trials
-
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
NCT03906253 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream
NCT03899064 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light
NCT00432224 ·Status: COMPLETED ·Phase: NA
-
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
NCT00367224 ·Status: COMPLETED ·Phase: NA
-
Photodynamic Treatment of Actinic Keratoses With Different Light Doses
NCT01541228 ·Status: COMPLETED ·Phase: NA
-
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
NCT00129415 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.
NCT02251756 ·Status: COMPLETED ·Phase: NA
-
Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
NCT00129428 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Image Data Collection of Tanned Skin During Phototherapy Treatment Using a Multi-spectral Camera
NCT05692544 ·Status: UNKNOWN
-
Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis
NCT01402414 ·Status: TERMINATED ·Phase: NA
-
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases
NCT03340155 ·Status: UNKNOWN ·Phase: NA
-
Pain Management During a Photodynamic Therapy Session on the Vertex for Actinic Keratosis: Tumescent Anesthesia Interest
NCT04779255 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn
NCT00441051 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients
NCT03718962 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities
NCT05359419 ·Status: UNKNOWN ·Phase: PHASE4
-
Protective Effect Assessment of Foto Ultra Isdin Solar Allergy Fusion Fluid on the UVA Induced PLE
NCT05320315 ·Status: COMPLETED ·Phase: NA
-
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
NCT00756288 ·Status: WITHDRAWN ·Phase: NA
-
Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types
NCT00386204 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light Exposure
NCT06654102 ·Status: COMPLETED ·Phase: NA
-
Daylight Photodynamic Therapy for Actinic Keratosis
NCT03322293 ·Status: COMPLETED ·Phase: PHASE1
-
Photodynamic Therapy Incubation Times for Actinic Keratosis
NCT03066843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
UVA1 Light for Treatment of Scleroderma and Similar Conditions
NCT00476801 ·Status: COMPLETED ·Phase: NA
-
Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses
NCT06545396 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
NCT03013647 ·Status: UNKNOWN ·Phase: NA
-
Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
NCT00615355 ·Status: COMPLETED ·Phase: NA